2018 March

FDA Nodded Sunovion’s Latuda for Bipolar Depression in Pediatric Patients

On March 8, 2018, the U.S. Food and Drug Administration approved the expanded use of the anti-psychotic drug Latuda (also referred to as lurasidone HCI) for a new indication – to […]

Recent researches about cancer chemotherapy

In recent years, scientists have made several breakthroughs in the research about cancer chemotherapy. Here, we sort out the studies about cancer chemotherapy. 1.Modular gene enhancer promotes leukemia and regulates […]

The introduction and synthesis route of small molecule kinase inhibitors approved by FDA in 2017

A total of seven new small molecule kinase inhibitors have been approved by FDA in 2017. Protein kinases form a very large family of signaling proteins, with more than 500 […]